News Headlines Article

Drug Companies Face Federal Inquiries
New York Times

At least a dozen major drug and device makers are under investigation by federal prosecutors and securities regulators in a broadening inquiry of bribery allegations as to whether the companies may have made payments to foreign doctors and health officials.

In previous investigations, federal officials have charged that many of these kinds of payments were made to encourage doctors to order their products.

Commands